University of Maryland School of Medicine Dean Mark T. Gladwin, MD, along with University of Maryland Medical Center (UMMC) ...

Researchers at the University of Colorado Cancer Center have discovered a novel therapy combination that could offer new hope to ovarian cancer patients who do not respond to existing treatments.

Radiology emeritus professor Jan Lotz has obtained his PhD in applied ethics from Stellenbosch University at the age of 78.

Cancer Research UK's Centre for Drug Development is sponsoring and conducting the phase I/II clinical trial of ALETA-001, the lead agent in Aleta Biotherapeutics' portfolio. Additional clinical trial ...

You may not realize you’ve benefited from HIV research. But if you’ve received a treatment that was approved through a recent clinical trial, received a CAR T cell for your cancer, or even just taken ...

People with intellectual disabilities will sit at the heart of a new research partnership between universities and industry that will develop new, more inclusive assessments for a wider spectrum of ...

Researchers say this is the first combination therapy that targets two different cancer survival mechanism: PARP and WNT signaling.

Rules that allow for this expanded scope without requiring physician collaboration vary by state. Currently in the US, 27 ...

Scientists at Northwell Health's Feinstein Institutes for Medical Research have uncovered a critical mechanism driving vascular cognitive impairment (VCI), the world's second most common form of ...

NEW YORK, Dec. 10, 2025 /PRNewswire/ -- Ro, the leading direct-to-patient healthcare company, today published the first study to evaluate both the long-term weight loss and safety outcomes of ...

An updated Canadian guideline on HIV prevention addresses the expanding range of medications available to reduce the risk of ...

Cynthia M. Otto, DVM, PhD, DACVECC, DACVSMR, expands on research conducted by the Penn Vet Working Dog Center research. She ...